Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

PFAS are causing significant harm to the environment, people, pets, and wildlife, but it's not clear that proposed solutions ...

The tool identifies high-risk patients, creates care pathways, and alerts doctors, nursing staff, and palliative care teams ...

The prolonged use of muscle relaxants may offer pain relief in specific syndromes but can be associated with side effects ...